Tumour Cells in the Blood with Special Reference to Pre- and Post-Hepatic Blood by Fletcher, W. S. & Stewart, J. W.
33
TUMOUR CELLS IN THE BLOOD WITH SPECIAL REFERENCE
TO PRE- AND POST-HEPATIC BLOOD
W. S. FLETCHER AND J. W. STEWART
From the Department of Surgical Studies and the Bland-Sutton Institute ofPathology,
The Middlesex Hospital, London, W.1.
Received for publication January 29, 1959
BLOOD stream metastasis of malignant tumours has long been recognised.
Over the years there have been sporadic reports of atypical cells in the blood
ofcancer patients but it is onlywith the advent oftechniques forisolating different
types of cells from whole blood by utilising minor differences in their gravity
(Fawcett and Valle, 1952) that it has been possible to demonstrate definitely
such tumour cells.
Engell (1955) reported that in 59 per cent of patients with carcinoma of the
rectum or colon either definite malignant cells, or atypical cells suggestive of
malignant cells, were demonstrable in the venous blood draining the tumour area.
He also found tumour cells in the blood draining other tumour sites and in the
peripheral blood. Other investigators, using slightly different separation tech-
niques, have confirmed Engell's findings. Most noteable of these are Sandberg
and Moore (1957) and Sandberg et al. (1958), whose technique depends on the
rapid sedimentation of erythrocytes with bovine fibrinogen, and Roberts et al.
(1958) and Cole et al. (1958) who refined this technique by layering the tumour
cells at an albumin interface of known specific gravity after sedimentation of the
erythrocytes with bovine fibrinogen.
Our own work falls into two parts. We first of all investigated patients with
a variety of tumours, but particularly with tumours of the parotid and breast.
Having found that we were able to identify tumour cells both in the blood draining
tumour sites and in the peripheral venous blood, we have attempted to determine
to what extent tumour cells are filtered from the blood by the liver in patients
either with primary gastro-intestinal carcinoma or with abdominal secondary
deposits.
METHOD
For the second part of our studies blood was taken before and after it entered
the liver. Fig. 1 demonstrates the way in which the post-hepatic samples were
taken. A catheter is passed under fluoroscopy through the right side of the heart
and into the right and then the left hepatic vein, and a 5 ml. sample of blood is
taken from each vein. At the same time 5 ml. sample of peripheral blood is also
taken. As it is difficult to take pre- and post-hepatic blood simultaneously at
operation, the post-hepatic is taken pre-operatively. The pre-hepatic samples are
taken at operation from the portal vein as soon as the abdomen is opened and with
minimal handling of the tumour. Again a simultaneous 5 ml. of peripheral blood
sample is taken.
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The samples are processed immediately using a slight modification of SanJ-
berg and Moore's (1957) technique. The blood is put directly into a tube con-
taining 1 mg. of heparin and 80 mg. of bovine fibrinogen in 2 ml. ofwater, and
allowed to stand until the erythrocytes sediment. The supernatant fluid is then
pipetted offand centrifuged at 1000 r.p.m. for 5 minutes. The supernatant plasma
is decanted and the residual portion of cells resuspensed in the remaining fluid.
A known aliquot of this suspension is smeared on four slides and stained with
Leishman's stain; two are counter-stained with peroxidase, which provides a
xt"' A)+
FIG. 1.-Diagram showing catheters in position for taking hepatic
and pcrtal samples of blood.
contrasting background in that neutrophils are peroxidase-positive while tumour
cells, lymphocytes and monocytes are peroxidase-negative. Examination of
approximately one-fourth ofone peroxidase, and one fourth ofone non-peroxidase
stained smear for each sample was then carried out by one ofthe authors (W.S.F.)
and the possible malignant cells marked. These were reassessed by the other
author (J.S.) and possible blood cells excluded.
The criteria for determining whether cells are tumour cells have been discussed
by numerous authors (Engell, 1955; Sandberg and Moore, 1957; Roberts et al.
1958). Clumps of large atypical cells with large hyperchromatic nuclei in which
one or more nucleoli can be seen contribute the classical picture. In our cases
whenever possible a tumour smear was made for comparison.
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Smears are classified as definitely positive and negative, but there remain a
number which contain atypical hyperchromatic non-blood cells which cannot be
definitely identified as malignant. These we have classified as suspicious. Fig.
2-7 show examples ofthe types of cells we have seen.
RESULTS
Our complete results in all the 51 patients that we have investigated to date
are given in Table I. The 4 cases ofmixed tumour ofthe parotid and the one case
of benign gastric ulcer served as controls, and as expected showed no tumour
cells in the blood. It will be seen that tumour cells or suspicious cells were found
in a significant proportion ofall cases either in regional vein blood, or in peripheral
vein blood, or in both. The frequency varied in the different groups, and was
highest in the regional vein blood in cases oftumours ofthe gastro-intestinal tract,
though the figures are too small for final conclusions on this point.
Further Analysis ofthe Pre- and Post-Hepatic Blood Studies
Fourteen patients had blood taken from the hepatic veins. Five, a hetero-
geneous group including cases of secondary deposits in the liver from carcinoma
of the breast, did not have portal vein blood taken; none of these 5 patients
showed tumour cells in the hepatic vein blood. Nine patients had samples taken
both of pre-hepatic (i.e. portal) and of post-hepatic (i.e. hepatic vein) blood. In
4casestheportalbloodwaspositiveformalignant cellsandinafurther4suspicious,
making a total of 8 out of 9 cases positive or suspicious. The hepatic vein blood
was positive in one case and suspicious in a furthercase,making a total of 2 out of
9 positive or suspicious. One of the 9 patients, an advanced carcinoma of the
TABLE I.-Results of Examination of Regional, Peripheral and Hepatic Blood
Samplesfor Tumour Cells
A B C D
A.."' · t --'4----- A..._ , .__._.
Regional vein Peripheral (1) Hepatic Peripheral (2)
blood vein blood vein blood vein blood
Number Pos. Pos. Pos. Pos.
of + + + +
cases Pos. Susp. Susp. Pos. Susp. Susp. Pos. Susp. Susp. Pos. Susp. Susp.
Ca. breast . . 19 3/15 3/15 6/15 3/10 2/10 5/10 0/2 .-
Ca. parotid . . 4 2,4 0/4 2,4
Mixed parotid 4 0/4 0/4 0/4
tumour
Gastro-intestinal Ca. 17 8/15 4/15 12/15 1/11 2/11 3/11 1/14 1/14 2/14 1/9 2/9 3/9 Miscellaneous Ca. 6 2/4 1,4 31'4 0,3 1/3 1/3 - -.
(Thyroid, bone, kid-
ney, lip, melanoma)
Benign ulcer . . 1 0/1 0/1 0/1
Results expressed as No. Pos. or Susp. /No. patients sampled.
Total cases = 51.
Pos. = Positive for tumcur cells.
Susp. = Suspicious of tumour cells (hyperchromatic non-blood cells).
Peripheral vein blood (1) = All cases in which peripheral vein samples were taken.
Peripheral vein blood (2) = Cases which had in addition peripheral vein samples at time of portal samples.W. S. FLETCHER AND J. W. STEWART
stomach with secondary deposits in the liver, showed large numbers of tumour
cells in blood taken from all sites-portal vein, hepatic vein and peripheral venous
blood, but they were much more numerous in the portal than in the hepatic blood.
DISCUSSION
Our results confirm those of Engell (1955), Moore, Sandberg and Schubarg
(1957), and Cole et al. (1958) in showing that tumour cells can frequentlybe demon-
strated in the blood in cases of malignant disease. Though our figures are too
small and the cases too heterogeneous forprecision, both in site ofgrowth, malig-
nancy and degree of spread the entrance of tumour cells into the blood stream
in malignant disease is clearly a frequent event, particularly since their demon-
stration represents the situation in a small sample at the moment ofsampling only.
Blood borne metastasis, though frequent, is not as frequent as this, and most
tumour cells which get into the blood stream must be destroyed. The possibility
exists that the attempted destruction of cells in the blood stream by chemo-
therapeutic agents might make matters worse by lowering the resistance of the
normal tissues unless selective agents were discovered.
The pre- and post-hepatic blood investigations show that the liver is a highly,
but not completely, efficient filter of tumour cells reaching it by the portal vein,
a fact already well known both from morbid anatomy and from experimental
studies (Patey, 1937). If the one patient is excluded who had large numbers of
malignant cells in all samples and who might be likened to an in vivo tissue culture
of malignant cells, 7 out of 8 portal vein blood samples contained either tumour
cells or suspicious cells, while only one of 8 samples ofhepatic vein blood from the
same patients was suspicious of tumour cells.
Though again the figures are too small to be significant, it will be noted that
the peripheral veinblood contained tumour cells or suspicious cells morefrequently
than the hepatic vein blood, both in the samples taken before operation (Table I,
Column B) and in those taken at operation (Table I, Column D). If this finding
were confirmed, it would suggest either that tumour cells are released from the
liver sporadically and that the finding of them in the hepatic vein depended on
the chances oftiming; orthat the cells enter the systemic blood stream byanother
route. An obvious alternative route would be through lymphatics and the
thoracic duct.
EXPLANATION OF PLATE.
FIG. 2.-Seven tumour cells from a patient with carcinoma of the stomach. Also several
peroxidase-positive neutrophils as well as erythrocytes and lymphocytes.
FIG. 3.-Two malignant cells from the same patient with a peroxidase-positive neutrophil
near by for comparison.
FIG. 4.- Three tumour cells, one of which is a typical signet ring cell from the samne patient
as Fig. 2 and 3.
FIG. 5.-A large clump of tumour cells from the external jugular vein of a patient with
carcinoma of the parotid.
FIG. 6.-An atypical hyperchromatic non-blood cell.
FIG. 7.-A rolled up sheet of endothelial cells scraped from a vein at autopsy. Note pale
staining, and, although poorly seen in reproduction, the very pale cytoplasm holding the
cells together.
36BRITISH JOURNAL OF CANCER.
ee 2..w _.A
.1. ,
2
;fr
...
4
AN-
A* d!! f
_
7.
Stewart and Fletcher.
Vol. XIII, No. 1.TUMOUR CELLS IN BLOOD 37
SUMMARY
1. Tumour cells or suspicious cells were found in a significant proportion of
51 cases, both in blood draining malignant tumour sites and in peripheral venous
blood.
2. Tumour cells or suspicious cells were found in the portal blood in 8 out of
9 cases of carcinoma ofthe gastro-intestinal tract, but in only 2 ofthe same cases
in hepatic vein blood.
3. There is a suggestion that some tumour cells from carcinomas ofthe gastro-
intestinal tract may reach the systemic circulation by the lymphatic route.
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